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Abstract:  This study aims to determine and empirically prove the effect of tax rates, 
earnings per share and sales growth on stock prices in health and 
pharmaceutical sector companies listed on the Jakarta Stock Exchange for 
the 2018-2020 period. This research uses quantitative research that is 
associative. The population in this study is the health and pharmaceutical 
sector companies listed on the Jakarta Stock Exchange in 2018-2020, as 
many as 17 companies. Sampling was done by using a purposive sampling 
technique, total 16 companies for three years or 48 data were obtained. Data 
analysis in this study was carried out using multiple linear regression 
analysis. The results showed that partially earning per share had a positive 
and significant effect on stock prices, while tax rates and sales growth had 
no significant effect on stock prices. Simultaneously tax rates, earnings per 
share and sales growth have a significant effect on stock prices.  
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1. Introduction  
Currently, the world is facing a COVID-19 pandemic. The worldwide economy is reported to 
have experienced a sharp decline due to Covid 19. Various government policies in dealing 
with COVID-19 have had an impact on various industrial sectors. Lockdown policies carried 
out by several countries in the world have been able to reduce the spread of the Covid-19 
virus, but this is not the case with industrial conditions in the world. Based on data from CNN 
Indonesia, there are several international companies, such as Pizza Hut, which is held by 
NPC International, which went bankrupt due to debts of US$ 1 billion. A Japanese retail 
company, Muji, also went bankrupt because it was burdened with debts of US$ 50 million to 
US$ 100 million because the company had to switch to online operations and closed several 
outlets. Brooks Brothers, a US menswear retailer, filed for bankruptcy and fired nearly 700 of 
its employees despite receiving a loan of US$75 million for operating costs. These three 
companies are a small part of the many companies that, based on their performance, went 
bankrupt due to the inability to pay debts and the inability to adapt strategies related to the 
Covid19 pandemic (Cnn Indonesia, 2020). Almost all countries in the world have decided on 
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a lockdown policy, but this is not the case with Indonesia. The President of Indonesia, 
Jokowi, did not decide on a lockdown in the hope that people's economic activities can still 
run. The Indonesian government also provided capital stimulus and concessions in debt 
payments from companies in sectors affected by Covid19. An exception to this policy is 
given to companies in the health and pharmaceutical sectors which are seen as sectors 
because it is considered that the pharmaceutical and health sectors are the main sectors that 
play a role in the process of recovering from the Covid-19 pandemic. Products from the 
health and pharmaceutical sector companies are needed by the community so they are 
considered to be able to maintain the company without government assistance. Thus debt 
becomes the main priority / benchmark for companies that are able to survive or go bankrupt 
(cnnindonesia, 2020) 
Pharmaceutical companies that have supply chains from other countries will have 
difficulty with the restriction policies between countries. One example is that the global 
dependence on Indian generics is likely to be a complex international challenge. There is no 
reliable substitute for API supplies, or available production capacity, and more importantly, 
any country with the potential to build manufacturing is likely to focus on national needs 
rather than exports or development assistance. The state of the pharmaceutical industry in 
relation to the process of research and development of drugs will also determine the impact of 
the pandemic on one-fifth of the world's population. (Guerin et al., 2020). Thus, for 
pharmaceutical and health companies, research and development activities are a determinant 
of the sustainability of businesses or other industries. 
Ayati et al. (2020) mentions that there are short-term and long-term impacts of Covid 19 
on pharmaceutical and health companies. Short-term impacts include changes in demand 
related to panic buying of health products and drugs, shifts in communication and promotion 
to long-distance interactions through telecommunications and tele-health, and changes in the 
direction of research and product development focusing on products related to vaccines or 
Covid 19 medicines. While the long-term impacts are delays in approval for pharmaceutical 
products that are not related to COVID, the move towards self-sufficiency in the 
pharmaceutical industry, slowing growth in the pharmaceutical industry, and changing trends 
in consumption of health-related products.The COVID-19 pandemic condition requires 
management to make quick and appropriate strategic change decisions in order to maintain 
the stability of the company's performance. The right strategy will determine the company's 
future, but seeing the number of companies that have gone bankrupt due to the inability to 
repay loans, financial performance is a major factor in determining the direction of company 
policy, especially considering the financial market conditions which in early March 2020 
experienced a decline due to changes in demand and demand. sales system thus necessitating 
the closure of offline stores. This is evidenced by the negative performance of pharmaceutical 
stocks in Indonesia in the first quarter of 2020 with a PER of –0.44. In the first quarter of 
2020, it is still possible for companies that have internal financing sources to carry out 
company operations. However, this is not the case with companies that depend entirely on 
external financing in the form of debt and shares. Seeing the declining stock market 
conditions at the beginning of the COVID-19 pandemic, it is possible to disrupt companies 
that use financing sources in the form of shares. Thus, debt becomes a way out for companies 
that want their companies to continue operating. The condition of the pharmaceutical sector's 
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stock performance began to show changes in the second quarter with a PER value of 25.71 
(idx.co.id, 2020). This change can indicate a rapid adaptation process of the company in 
changing the company's performance. The company's adaptations related to this performance 
can come from the management and the strategies carried out by the company. Based on the 
Covid 19 phenomenon above, several things that are a source of strength for pharmaceutical 
and health companies are R&D activities and company strategy. 
The company's performance measurement can actually not only be measured using 
the PER ratio but can also be measured by other methods. The center of the company's 
growth comes from the performance resulting from the efficiency and effectiveness of 
operational activities. This performance contributes to the company's value to shareholders. 
In general, the definition of business performance and its measurement has been put forward 
differently by a number of experts such as the process of measuring process, efficiency, and 
effectiveness and the application of measurement metrics to measure efficiency and 
effectiveness (Neely et al. 1994). Performance measurement and its metrics need to be 
integrated with all financial and non-financial dimensions, external and internal factors, as 
well as monetary and non-monetary requirements, with an objective focus on measuring 
financial elements (Venkatraman et al. 1986). In 1943, based on Ewoh (2011) the term 
performance measurement was introduced to the business sector after the implementation of 
the International City Management Association (ICMA) which then used various 
performance measures. Kaplan et al. (1992) introduced the Balanced Score Card (BSC) as a 
popular measurement method for measuring business performance, both financial and non-
financial. The measurement method aligns the company's mission and strategy into a set of 
performance measures in four perspectives, namely operational, customer, financial, and 
growth perspectives to make better decisions. Along with the application of non-financial 
indicators, financial performance measures are considered a major problem in creating value 
for shareholders in terms of cash flow and cost of capital. A large number of financial 
measures are used; however, great attention of researchers and companies still refers to 
traditional financial indicators. This situation is in accordance with the disclosure of financial 
statements that underline monetary and voluntary accounting information. Traditional 
financial indicators, which are mostly used by companies such as profit and loss, income 
statement line items, operating income, income before tax and interest (EBITA), return on 
assets (ROA), return on equity (ROE), return on capital investment ( ROIC), earnings per 
share (EPS) and dividends per share (DPS) which focus on the company's performance from 
past activities. In addition, this financial indicator is very important for users because it 
reflects how well the strategy is implemented in the company, what goals can be achieved 
and also the tendency of the company's strategic orientation. Some critics argue that this 
traditional financial performance measurement is no longer adequate for shareholders 
because of past financial information and it is still unclear about the relevance between the 
contained earnings information and capital markets. 
The theory that underlies this research is Signaling Theory which states that how 
companies should provide signals in the form of information to users of financial statements 
about what management has done to realize the owner's wishes. Signaling theory emphasizes 
the importance of information released by the company on investment decisions by outsiders. 
Information is very important for investors and business people. Because information 
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essentially presents information, notes or descriptions for past, present, and future conditions 
for the survival of the company. Complete, relevant, accurate and timely information by 
investors in the capital market as an analytical tool for making investment decisions. Tax is a 
very basic thing, in collecting taxes it must be based on statutory regulations. In essence, the 
people who bear the tax burden are the people, the issue of the tax base and tax rate must go 
through the approval of the people represented by the people's representative institutions and 
the results of the approval are set forth in a law that must be obeyed by every party subject to 
tax obligations (Rahayu, 2010: 23 ). Tax collections carried out by the government are carried 
out in such a way as not to harm the community, therefore a tax rate is needed so that tax 
collection is balanced between the community and the government so that no party is harmed 
and there is no mistake between the community and the government. If capital gains are taxed 
at a lower rate than the tax on dividends, then the stock has a higher growth rate,but 
conversely if capital gains are taxed the same as the tax on dividends, then the capital gains 
gain will be reduced. However, the tax on capital gains is still better than the tax on 
dividends, because the tax on capital gains is only paid after the shares are sold, while the tax 
on dividends must be paid annually after the dividend payment (Sartono, 2011).Earning Per 
Share or income per share is a form of giving benefits given to shareholders from each share 
owned (Fahmi, 2012: 96). EPS is the result or income that will be received by shareholders 
for each share they own for their participation in the company. Earnings per share is usually 
an indicator of earnings that investors pay attention to, which generally has a correlation. 
There is a strong relationship between profit growth and stock price growth. According to 
Ang. R (1997:22), EPS is a comparison between net profit after tax in one financial year with 
the number of shares issued (outstanding shares). This net profit after tax is commonly 
referred to as earnings after tax. Sales growth reflects the manifestation of past investment 
success and can be used as a prediction of future growth. Sales growth is also an indicator of 
demand and competitiveness of companies in an industry. The growth rate of a company will 
affect the ability to maintain profits in funding opportunities in the future (Barton et al. 1989). 
High sales growth, it will reflect increased income so that dividend payments tend to 
increase. Sales growth is defined as an increase in the number of sales from year to year or 
from time to time (Kennedy et al., 2013). Kusumajaya (2011) suggests that the company's 
growth rate as measured by sales growth affects the value of the company or the company's 
stock price because company growth is a sign of good company development which has a 
positive response from investors. There is a tendency for companies with high growth rates to 
produce high levels of future cash flows and market capitalization, thus enabling companies 
to have a low cost of capital (Sriwardany, 2006). According to Barton et al. (1989) companies 
with a growth rate will affect the ability to maintain profits. 
Pranata et al. (2015) in his research uses type of causal quantitative research and the 
sample in this study is the annual financial report PT. Telekomunikasi Indonesia, Tbk period 
2001-2014 show that tax rate has influences to the stock price for about 32.6%. Those 
research was arguing supported by Putra and Tjaraka (2016) in his research of manufacturing 
companies listing on the Stock Exchange in the period the change in corporate income tax 
rate is 2008-2010. The research of Putra and Tjaraka (2016) shows that indicate that the 
phenomenon of corporate income tax rate changes have no significant effect either on the 
deferred tax liabilities and stock returns, while deferred tax liabilities had a positive effect on 
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stock returns. Results of this research concluded that the deferred tax liabilities can not be a 
mediator or intervening variable between corporate income tax rate changes and stock 
returns. 
 
H1: Tax rate has a significant effect on stock price 
 
 Pratiwi and Amelia (2020) do causal associative research which aims to analyze the 
relationship between one variable with another. The population in Pratiwi and Amelia are all 
financial reports on PT.Indofood Sukses Makmur Tbk. The sample used is the financial 
statements at PT. Indofood Sukses Makmur Tbk from 2009-2018. The results of Pratiwi and 
Amelia (2020) showed that the CR, DER and EPS significantly influence stock prices. The 
research of Lilianti (2018) also shows that Earnings Per Share (EPS) has influence on stock 
prices in pharmaceutical sub-sector companies on the Indonesia Stock Exchange (IDX). 
Santy (2017) in her research also shows that earnng per share give significant positive impact 
towards stock price.  
 
H2: Earning per share has a significant effect on stock price  
 
 Sales growth reflects the company's prospects in the future. If the company has increased 
profits, then  sales growth also increase and the company's performance is getting better from 
year to year. Thus, it will also have an impact on the stock price likely to rise because 
basically stock prices are influenced by profits in the future. But, some research shows 
opposite. Pratama (2014) in his research shows that Sales Growth has a negative and 
insignificant effect on stock prices. The results of this study are supported by research by 
Novitasari (2015) where sales growth has a negative and insignificant effect on stock prices 
of manufacturing companies. Likewise Deitiana (2011) which shows that sales growth has no 
effect on stock prices. So, it still needs research to prove that sales growth has significant 
effect towards stock price. 
 
H3: Sales Growth has significant effect on stock price 
 
2. Research Method 
The dependent variable in this study is the stock price of pharmaceutical and health sector 
companies from 2018-2020. Shares are securities which are a sign of ownership of a person 
or entity in a company (Hin, 2008). Profits derived from share prices due to dividend 
payments will be offset by a decrease in share prices due to the purchase of new shares, 
therefore shareholders can receive cash in the form of capital gains and shareholder 
prosperity is not affected by current or future dividend policies (Sartono , 2008). The share 
price is the closing nominal value of the participation or ownership of a person or entity in a 
company that applies regularly in the capital market in Indonesia (Kesuma, 2009:40). 
The first independent variable in this study is the tax rate is the imposition of the amount 
of tax that must be paid by the tax subject on the tax object that is his responsibility. The tax 
rate used in this study is based on Law no. 36 of 2008 concerning Income Tax Article 17 
paragraph (1) part b states that the general tax rate imposed on corporate taxpayers is 25%. In 
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2020, through Government Regulation (PP) Number 30 of 2020 concerning Reduction of 
Income Tax Rates for Domestic Taxpayers in the Form of Limited Liability Companies, the 
corporate income tax rate is reduced to 22%. The second independent variable in this study, 
namely earnings per share or income per share is a form of giving benefits given to 
shareholders from each share owned. Earning per share is usually the concern of investors or 
potential investors, using the following formula: 
 
Earning per Share = earning after tax/ Number of shares outstanding 
 
The third independent variable in this study is sales growth, namely the increase or 
decrease in sales from year to year or from time to time measured as a percentage of sales. 
The indicator used to measure sales growth is to compare the current year's sales minus the 
previous year's sales with the previous year's sales multiplied by one hundred percent, using 
the following formula: 
PP =(𝑆𝑡 − 𝑆𝑡−1)/𝑆𝑡−1× 100% 
 
The population is a generalization area consisting of objects or subjects that have certain 
qualities and characteristics determined by researchers to be studied and then drawn 
conclusions (Sugiyono, 2016: 81). The population referred to in this study are pharmaceutical 
and health sector companies listed on the Indonesia Stock Exchange in 2018-2020, which are 
17 companies and have been published. The sample is part of the number and characteristics 
possessed by the population. The sample in this study was taken as many as 16 companies 
which were measured using purposive sampling method. From a population of 17 companies, 
there is 1 company whose data is incomplete so that there are only 16 companies that are the 
sample of this study. 
Data collection in this study was carried out using the data collection method to the 
Indonesia Stock Exchange, to be analyzed and proven that these variables had a significant 
effect. In making this research, the data collection method used is through library research, 
namely research conducted by collecting materials or data related to the object of discussion, 
obtained through library research, namely by studying, researching, reviewing and reviewing 
books and literature. accounting journal. Apart from research bibliography can be done 
through documentation techniques, namely data collection techniques carried out by 
collecting all secondary data and all information used to solve problems in the document. 
 
Table 1.  Sample Criteria 
No. Criteria Amount 
1. Pharmaceutical and Health Sector Companies 17 
2. Pharmaceutical and Health Sector Companies not listed on the 
Jakarta Stock Exchange 
0 
3. Pharmaceutical and Health Sector Companies do not have complete 
financial statements, balance sheets, and stock data 
1 
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 Data analysis is an activity after data from all respondents or other data sources are 
collected. Activities in analyzing data are grouping data based on variables and types of all 
respondents, presenting data from each variable studied, performing calculations to answer 
the problem formulation and performing calculations to test hypotheses that have been 
proposed (Sugiyono, 2016:147). The analysis in this study will use SPSS (Statistical Product 
and Service Solution) version 22. 
 
3. Results and Discussion 
3.1. Results 
The research objects used in this study are pharmaceutical and health sector companies listed 
on the Indonesia Stock Exchange in 2018-2020. Companies that are taken as samples are 
only companies that meet the sample criteria that the researchers set themselves. The data 
was obtained from the Indonesia Stock Exchange website, namely www.idx.co.id. The 
sample used in this study were 16 companies which are manufacturing companies listed on 
the Indonesia Stock Exchange by considering the predetermined criteria. Table 1 shows a list 
of company names that were sampled in this study. 
 
Table 2. Sample of Pharmacy and Health Sector Company Listed in Jakarta Stock Exchange 
No. Company Code 
1. PT Darya-Varia Laboratoria Tbk. DVLA 
2. PT Indofarma (Persero) Tbk. INAF 
3. PT Kimia Farma (Persero) Tbk. KAEF 
4. PT Kalbe Farma Tbk. KLBF 
5. PT Merck Tbk MERK 
6. PT Phapros, Tbk PEHA 
7. PT Pyridam Farma Tbk PYFA 
8. PT Industri Jamu dan Farmasi Sido Muncul Tbk SIDO 
9. PT Tempo Scan Pacific Tbk TSPC 
10. PT Medikaloka Hermina Tbk HEAL 
11. PT Mitra Keluarga Karyasehat Tbk MIKA 
12. PT Prodia Widyahusada Tbk PRDA 
13. PT Royal Prima Tbk PRIM 
14. PT Sarana Meditama Metropolitan Tbk SAME 
15. PT Siloam International Hospitals Tbk SILO 
16. PT Sejahteraraya Anugrahjaya Tbk SRAJ 
 Source : processed data, 2021 
 










(Constant) -2606.106 3568.988  -0.730 0.469 
X1 17099.410 14648.059 0.156 1.167 0.249 
X2 5.907 1.873 0.422 3.153 0.003 
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X3 -1861.788 1250.917 -0.197 -1.488 0.144 
Source : processed data, 2021 
 
Table 4. The Result of ANOVA 





Regression 26572012.269 3 8857337.423 4.422 0.008 
Residual 88140572.399 44 2003194.827   
Total 114712584.667 47    
Source : processed data, 2021 
 
Table 5. The Result of  Model Summary 




 .232 .179 
  Source : processed data, 2021 
 
From Table 3, the regression equation model can be obtained as follows: Y = -2606.106 
+ 17099.410 X1 + 5.907 X2 - 1861.788 X3. Based on the regression equation, the value of α 
= -2606.106 ; this means that if the tax rate variable, earning per share, and sales growth are 
constants, then the stock prices is negative or decrease. The value of β1 = 17099.410, so the 
tax rate variable has a positive influence on stock price, meaning that if tax rate variables 
increase, the stock price will increase, assuming the earning per share and sales growth 
remain constant. The value of β2 = 5.907, so the earning pers share has a positive influence 
on stock price, meaning that if the earning per share increases then stock price will increase, 
assuming the tax rate and sales growth remain constant. The value of β3 = -1861.788, 
meaning that the sales growth has a negative effect on the stock price; if the sales growth 
increase, the stock price will decrease, assuming that the tax rate and earning per share 
remain constant. 
Tax rate (X1) obtained a t-value of 1.167 with a significant value of 0.249 > 0.05, which 
means that tax rate have no significant effect on the stock price among Pharmacy and Health 
Company Sector, so Hypothesis 1 is not proved. Earning per share (X2) obtained t-value of 
3.153 with a significant value of 0.003 <0.05, which means that the earning per share has a 
significant effect on the stock price among Pharmacy and Health Company Sector, so 
Hypothesis 2 is proved. Sales growth (X3) obtained a t-value of -1.488 with a significant 
value of 0.144 > 0.05 which means that the sales growth value has no significant effect on the 
stock price among Pharmacy and Health Company Sector, so Hypothesis 3 is not proved. 
Based on the results of the F test (Table 4), F value = 4.422 with a significant value of 0.008 
< 0.05, so that it can be concluded that together tax rate, earning per share, and sales growth 
have a significant influence on the stock price among Pharmacy and Health Company Sector. 
Based on the results of the coefficient of determination (Table 5), the value of the Adjusted 
R. Square of 0.179 means that tax rate, earning per share, and sales growth contribute 17.9 % 
to the stock price among Pharmacy and Health Company Sector, while the remaining 82.1% 
is influenced by other variables outside of this research.  
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3.2. Discussion 
The results of testing Hypothesis 1 show that tax rate have a not significant positive effect on 
the stock price among Pharmacy and Health Company Sector. The results of this study means 
that if tax rate is increase then the the stock price among Pharmacy and Health Company 
Sector increase. The results of this study are in opposite with the results of research from 
Pranata et al. (2015), also Putra and Tjaraka (2016) which state that tax rate has a significant 
positive effect on stock price. The results of testing Hypothesis 2 shows that the earning per 
share has a significant positive effect on the stock price among Pharmacy and Health 
Company Sector. The results of this study mean that if the earning per share is improved then 
the stock price among Pharmacy and Health Company Sector increases. The results of this 
study are in accordance with the results of research from Pratiwi and Amelia (2020) and 
Lilianti (2018) which stated that earning per share has a significant positive effect on stock 
price. The results of testing Hypothesis 3 show that the sales growth variable has a not 
significant negative effect on the stock price among Pharmacy and Health Company Sector. 
The results of this study mean that if the sales growth increased, the stock price among 
Pharmacy and Health Company Sector decrease. The results of this study are in accordance 
with the results of research from Deitiana (2011), Novitasari  (2015), and Pratama (2014) 
stating that sales growth has negative and not significant effect on stock price.  
 
4. Conclusion 
Tax rates have a positive effect and not significant to the stock price with individual 
parameter significant test results (t-test) is bigger than the level of significance. It is proven 
that every an increase in tax rates has no role in an effort to increase stock prices. Earnings 
Per Share has a positive effect to the Stock Price with the test results significant individual 
parameters (t-test) more smaller than the level of significance. This matter proven when 
earning per share goes up, then the stock price will experience enhancement. Sales growth 
has no effect to the stock price with the test results significant individual parameters (t-test) 
more greater than the level of significance. This can happened because the company did not 
evaluate sales for affect its stock price. Tax rates, earnings per share and sales growth jointly 
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